Cleared Traditional

K881255 - NOVA 12 NA/K/C1/TOTAL CARBON DIOXIDE/GL...

K881255 is the FDA 510(k) clearance for NOVA 12 NA/K/C1/TOTAL CARBON DIOXIDE/GL... by Nova Biomedical Corp.. It is a Class 2 Chemistry device (product code JGS) cleared through the Traditional 510(k) pathway after a 54-day FDA review.

K881255 · Nova Biomedical Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1988
Decision
54d
Days
Class 2
Risk

K881255 is an FDA 510(k) clearance for the NOVA 12 NA/K/C1/TOTAL CARBON DIOXIDE/GLUCOSE/UREA. Classified as Electrode, Ion Specific, Sodium (product code JGS), Class II - Special Controls.

Submitted by Nova Biomedical Corp. (Walham, US). The FDA issued a Cleared decision on May 16, 1988 after a review of 54 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1665 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nova Biomedical Corp. devices

Submission Details

510(k) Number K881255 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 23, 1988
Decision Date May 16, 1988
Days to Decision 54 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 88d · This submission: 54d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JGS Electrode, Ion Specific, Sodium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1665
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JGS Electrode, Ion Specific, Sodium

All 99
Devices cleared under the same product code (JGS) and FDA review panel - the closest regulatory comparables to K881255.
NOVA NUCLEUS CLINICAL CHEMISTRY SYSTEM
K894218 · Nova Biomedical Corp. · Sep 1989
CIBA CORNING MODEL 570 ALLIANCE I.S.E. MODULE
K892500 · Ciba Corning Diagnostics Corp. · Jul 1989
NOVA STAT PROFILE 6 ANALYZER + QUALITY CONTROL MAT
K880750 · Nova Biomedical Corp. · Jul 1988
NOVA STAT PROFILE 5 ANALYZER + QUALITY CONTROL
K874832 · Nova Biomedical Corp. · Feb 1988
ANALYTES SODIUM & POTASSIUM ASSAYED ON TECH RA(R)
K875263 · Technicon Instruments Corp. · Feb 1988
DART (R) ELECTROLYTE REAGENT SYSTEM
K874185 · Coulter Electronics, Inc. · Nov 1987